K-Lyte/Cl 25 Interactions
There are 144 drugs known to interact with K-Lyte/Cl 25 (potassium bicarbonate / potassium chloride), along with 9 disease interactions. Of the total drug interactions, 101 are major, 27 are moderate, and 15 are minor.
- View all 144 medications that may interact with K-Lyte/Cl 25
- View K-Lyte/Cl 25 disease interactions (9)
Most frequently checked interactions
View interaction reports for K-Lyte / Cl 25 (potassium bicarbonate / potassium chloride) and the medicines listed below.
- acetaminophen / propoxyphene
- acyclovir
- Adalat CC (nifedipine)
- Advair HFA (fluticasone / salmeterol)
- albuterol
- Align (bifidobacterium infantis)
- Allegra (fexofenadine)
- allopurinol
- alprazolam
- Amaryl (glimepiride)
- amlodipine
- atorvastatin
- Atrovent (ipratropium)
- Augmentin (amoxicillin / clavulanate)
- Azmacort (triamcinolone)
- cefdinir
- Ceftin (cefuroxime)
- cephradine
- chlordiazepoxide / clidinium
- Cipro (ciprofloxacin)
- citalopram
- Clarinex (desloratadine)
- Claritin Reditabs (loratadine)
- clindamycin
- clotrimazole topical
- colchicine
- Combivent (albuterol / ipratropium)
- Lasix (furosemide)
- lisinopril
- Zithromax (azithromycin)
K-Lyte/Cl 25 disease interactions
There are 9 disease interactions with K-Lyte / Cl 25 (potassium bicarbonate / potassium chloride) which include:
- dehydration/diarrhea
- dehydration
- familial periodic paralysis
- hyperkalemia
- renal dysfunction
- GI irritation
- acid/base balance
- alkalosis
- acidosis
Report options
QR code containing a link to this page
More about K-Lyte / Cl 25 (potassium bicarbonate / potassium chloride)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.